Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleBYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.AuthorsKu, Bo; Jho, Eun; Bae, Yeon-Hee; Sun, Jong-Mu; Ahn, Jin; Park, Keunchil; Ahn, Myung-JuPublicationInvestigational New Drugs, 2015, Vol 33, Issue 1, p12ISSN0167-6997Publication typeArticleDOI10.1007/s10637-014-0163-9